A chlorin-lipid nanovesicle nucleus drug for amplified therapeutic effects of lung cancer by internal radiotherapy combined with the Cerenkov radiation-induced photodynamic therapy-Reference-Cited by-同舟云学术

A chlorin-lipid nanovesicle nucleus drug for amplified therapeutic effects of lung cancer by internal radiotherapy combined with the Cerenkov radiation-induced photodynamic therapy

Published:2020 Issue:17 Volume:8 Page:4841-4851
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Cai Pengju¹²³⁴⁵,Yang Wenjiang⁶²³⁴⁵,He Zhesheng¹²³⁴⁵,Jia Huiju¹²³⁴⁵,Wang Huangwei¹²³⁴⁵,Zhao Wencong¹²³⁴⁵,Gao Liang⁷⁸⁹⁵,Zhang Zhiyong¹²³⁴⁵,Gao Fuping¹²³⁴⁵^ORCID,Gao Xueyun⁷⁸⁹⁵^ORCID

Affiliation:

1. CAS Key Laboratory for the Biological Effects of Nanomaterials and Nanosafety

2. Institute of High Energy Physics

3. Chinese Academy of Sciences

4. Beijing 100049

5. China

6. CAS Key Laboratory of Nuclear Radiation and Nuclear Energy Technology

7. Department of Chemistry and Chemical Engineering

8. Beijing University of Technology

9. Beijing 100124

Abstract

¹³¹I-BSA loaded chlorin-lipid nanovesicle constructed from Ce6 and LPPC conjugates for synergistic therapeutic effects of lung cancer by radiotherapy of ¹³¹I combined with Cerenkov Radiation (CR)-induced photodynamic therapy.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2020/BM/D0BM00778A

Reference38 articles.

1. Photodynamic therapy of cancer: An update

2. Photodynamic therapy for cancer